drugset
drugset / Trial / NCT02237742

A Study To Understand How The Body Reacts To A Low Dose Of PF-06427878 When Given In A Vein To Healthy, Adult, Males

NCT02237742 ↗

Phase 1 Completed 6 enrolled Pfizer
NaSingle-groupOpen-labelBasic science

Summary

To determine how the body reacts to a low dose of PF-06427878 when given in a vein over 30 minutes to healthy, adult, males.

Timeline

Start
2014-11
Primary completion
2014-11
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-06427878 Small molecule 100 ug Intravenous

Indications

No indication recorded.